GENTA INCORPORATED /DE/
4, 1998-01-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CAREMATRIX CORP, SC 13D/A, 1998-01-12
Next: GENTA INCORPORATED /DE/, 4, 1998-01-12



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Aries, Domestic Fund, LP
   787 Seventh Avenue
   48th Floor
   New York, NY  10019
2. Issuer Name and Ticker or Trading Symbol
   Genta Incorporated /DE/
   GNTA
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   12/29/97
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
12% Senior Secured  Co|$50.00  |12/31|C   | |$917,263(1)|D  |1/28/|when |Series D Con|18,345 |$822,50|$0(1)       |D  |            |
nvertible Bridge Notes|        |/97  |    | |           |   |97   |fully|vertible Pre|       |0      |            |   |            |
                      |        |     |    | |           |   |     | paid|ferred Stock|       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Series D Convertible P|$0.94375|12/31|C   | |18,345     |A  |5/29/|N/A  |Common Stock|1,943,8|$50.00 |26,745      |D  |            |
referred Stock, par va|        |/97  |    | |           |   |97   |     |            |41     |       |            |   |            |
lue $.001 per share   |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Series A Convertible P|$8.27   |12/2/|P   | |18,000     |A  |N/A  |N/A  |Common Stock|130,593|$130,99|18,000      |D  |            |
referred Stock, par va|        |97   |    | |           |   |     |     |            |       |3      |            |   |            |
lue $.001 per share   |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Series D Convertible P|$0.94375|12/29|J(3)| |350        |A  |12/31|6/30/|Common Stock|37,086 |(3)    |26,745      |D  |            |
referred Stock(2)     |        |/97  |    | |           |   |/97  |02   |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants(2)   |$0.94375|12/29|J(3)| |1,750      |A  |12/31|6/30/|Common Stock|1,750  |(3)    |19,250      |D  |            |
                      |        |/97  |    | |           |   |/97  |02   |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
Explanation of Responses:
(1)  Consists of $822,500 principal amount and $94,763 interest
(2)  The Series D Preferred  Stock and Class D Warrants are  components of units
     ("Units")  issuable upon exercise of warrants  ("Unit  Purchase  Warrants")
     exercisable from December 31, 1997 to June 30, 2002, at an initial exercise
     price of $110,000 per Unit. The Reporting Person may be deemed beneficially
     to own Unit Purchase  Warrants to purchase an aggregate of 0.35 Units. Each
     Unit consists,  initially,  of (i) 1,000 shares of Series D Preferred Stock
     of the Issuer, par value $0.001 per share, and (ii) 5,000 Class D Warrants.
     The Unit Purchase Warrants contain certain anti-dilution adjustments.
(3)  On December 29, 1997,  Paramount  Capital Inc.  designated  recipients (the
     "Paramount Warrant Designees") of the Unit Purchase Warrants. The Reporting
     Person was among the  Paramount  Warrant  Designees  and received such Unit
     Purchase  Warrants in connection with a private  placement of securities of
     the Issuer of which Paramount Capital, Inc. acted as placement agent.

SIGNATURE OF REPORTING PERSON
/s/Lindsay A. Rosenwald, M.D.
- ---------------------------------------------------------
Lindsay A. Rosenwald, M.D., President
Paramount Capital Asset Management, Inc., General Partner
Aries Domestic Fund, L.P.
DATE
1/9/98

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed.
        If space provided is insufficient, see Instruction 6 for procedure.


Potential persons who are to respond to the collection of information  contained
in this form are not  required to respond  unless the form  displays a currently
valid OMB Number.


<PAGE>

                                 Attachment A


       Reporting Person:                  The Aries Domestic Fund, L.P.
       Issuer:                            Genta Incorporated (GNTA)
       Statement For:                     December/1997

         Paramount Capital Asset  Management,  Inc.  ("Paramount"),  the General
Partner of the Aries Domestic Fund, L.P. (the "Partnership"), also serves as the
Investment  Manager to The Aries Trust (the  "Trust"),  a Cayman  Islands trust,
which also owns  securities of the Issuer.  Lindsay A.  Rosenwald,  M.D., is the
sole shareholder of Paramount.  Paramount and Dr. Rosenwald disclaim  beneficial
ownership of the securities held by the Partnership and the Trust, except to the
extent of their pecuniary interest therein.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission